Oxidative stress resistance and fitness-compensatory response in vancomycin-intermediate Staphylococcus aureus (VISA)

被引：2
|
作者：
Tan, Xin-Ee [1 ,3 ]
Neoh, Hui-min [1 ,2 ]
Cui, Longzhu [3 ]
Hiramatsu, Keiichi [2 ]
Jamal, Rahman [1 ]
机构：
[1] Univ Kebangsaan Malaysia, UKM Med Mol Biol Inst UMBI, Bangi, Malaysia
[2] Juntendo Univ, Sch Med, Dept Bacteriol, Tokyo, Japan
[3] Jichi Med Univ, Sch Med, Dept Infect & Immun, Div Bacteriol, Shimotsuke, Tochigi, Japan
来源：
CANADIAN JOURNAL OF MICROBIOLOGY | 2019年 / 65卷 / 08期
关键词：
vancomycin-intermediate Staphylococcus aureus; oxidative stress; virulence; fitness cost; METHIONINE SULFOXIDE REDUCTASES; VIRULENCE; MODEL;
D O I：
10.1139/cjm-2019-0048
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
In this study, vancomycin-intermediate Staphylococcus aureus (VISA) cells carrying vraS and (or) graR mutations were shown to be more resistant to oxidative stress. Caenorhabditis elegans infected with these strains in turn demonstrated lower survival. Altered regulation in oxidative stress response and virulence appear to be physiological adaptations associated with the VISA phenotype in the Mu50 lineage.
引用
收藏
页码：623 / 628
页数：6
相关论文
共 50 条
  • [1] Vancomycin-intermediate resistance in Staphylococcus aureus
    Hiramatsu, Keiichi
    Kayayama, Yuki
    Matsuo, Miki
    Aiba, Yoshifumi
    Saito, Michie
    Hishinuma, Tomomi
    Iwamoto, Akira
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2014, 2 (04) : 213 - 224
  • [2] Treatment of vancomycin-intermediate Staphylococcus aureus (VISA) endocarditis with linezolid
    Balkhair, Abdullah
    Al Muharrmi, Zakariya
    Darwish, Laila
    Farhan, Hatem
    Sallam, Mansour
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : E227 - E229
  • [3] Heteroresistance in Vancomycin-Intermediate Staphylococcus aureus (VISA), susceptible or resistant?
    Labarca, Jaime
    REVISTA CHILENA DE INFECTOLOGIA, 2015, 32 (05): : 497 - 498
  • [4] Effect of genetic background on the evolution of Vancomycin-Intermediate Staphylococcus aureus (VISA)
    Su, Michelle
    Davis, Michelle H.
    Peterson, Jessica
    Solis-Lemus, Claudia
    Satola, Sarah W.
    Read, Timothy D.
    PEERJ, 2021, 9
  • [5] Characterization of Infections with Vancomycin-Intermediate Staphylococcus aureus (VISA) and Staphylococcus aureus with Reduced Vancomycin Susceptibility in South Korea
    Jung Wan Park
    Hyungmin Lee
    Jung Wook Kim
    Bongyoung Kim
    Scientific Reports, 9
  • [6] Characterization of Infections with Vancomycin-Intermediate Staphylococcus aureus (VISA) and Staphylococcus aureus with Reduced Vancomycin Susceptibility in South Korea
    Park, Jung Wan
    Lee, Hyungmin
    Kim, Jung Wook
    Kim, Bongyoung
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [7] Clinical features and treatment outcomes of vancomycin-intermediate Staphylococcus aureus (VISA) and heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) in a tertiary care institution in Singapore
    Fong, R. K. C.
    Low, J.
    Koh, T. H.
    Kurup, A.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2009, 28 (08) : 983 - 987
  • [8] Clinical features and treatment outcomes of vancomycin-intermediate Staphylococcus aureus (VISA) and heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) in a tertiary care institution in Singapore
    R. K. C. Fong
    J. Low
    T. H. Koh
    A. Kurup
    European Journal of Clinical Microbiology & Infectious Diseases, 2009, 28
  • [9] Survivability and fitness cost of heterogeneous vancomycin-intermediate Staphylococcus aureus
    Singh, Avinash
    Singh, Sanjay
    Singh, Jyoti
    Rahman, Mohibur
    Pathak, Ashutosh
    Prasad, Kashi Nath
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2017, 35 (03) : 415 - 416
  • [10] Recognition and management of infections caused by vancomycin-intermediate Staphylococcus aureus (VISA) and heterogenous VISA (hVISA)
    Howden, BP
    INTERNAL MEDICINE JOURNAL, 2005, 35 : S136 - S140
12345